AKT1 and metabolic process: It can be inferred that NLRP3 inflammasome inhibition with MCC950 improves metabolism disorder via promoting autophagy through inhibiting PI3K/Akt/mTOR pathway in aged mice, which needs to be further studied by using autophagy inhibitors and the activator of PI3K/Akt/mTOR pathway.